![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Papers In Press, published online ahead of print October 7, 2004
Biochemistry, Kansas City University of Medicine and Biosciences, Kansas City, MO 64106
Corresponding Author: rjakobi{at}kcumb.edu
p21-activated protein kinase 2 (PAK-2) is a member of the p21-activated protein kinase (PAK) family of serine/threonine kinases. PAKs are activated by the p21 G-proteins Rac or Cdc42 in response to a variety of extracellular signals and act in pathways controlling cell growth, cell shape, cell motility, cell survival and cell death. PAK-2 is unique among the PAK family because it is also activated through proteolytic cleavage by caspase 3 or similar proteases to generate the constitutively active PAK-2p34 fragment. Activation of full-length PAK-2 by Rac or Cdc42 stimulates cell survival and protects cells from cell death whereas caspase-activated PAK-2p34 induces a cell death response. Caspase-activated PAK-2p34 but not full-length PAK-2 is rapidly degraded by the 26S proteasome. Stabilization of PAK-2p34 by preventing its poly-ubiquitination and degradation results in a dramatic stimulation of cell death. Although many proteins have been shown to interact with and regulate full-length PAK-2, little is known about the regulation of caspase-activated PAK-2p34. Here, we identify PS-GAP as a regulator of caspase-activated PAK-2p34. PS-GAP is a GTPase-activating protein for Cdc42 and RhoA which was originally identified by its interaction with the tyrosine kinase PYK-2. PS-GAP interacts specifically with caspase-activated PAK-2p34 but not with active or inactive full-length PAK-2 through a region between the GAP and SH3 domains. The interaction with PS-GAP inhibits the protein kinase activity of PAK-2p34 and changes the localization of PAK-2p34 from the nucleus to the perinuclear region. Furthermore, PS-GAP decreases the stimulation of cell death induced by stabilization of PAK-2p34.
J. Biol. Chem, 10.1074/jbc.M410530200
Submitted on September 13, 2004
Revised on October 4, 2004
Accepted on October 7, 2004
Identification and characterization of PS-GAP as a novel regulator of caspase-activated PAK-2
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. L. Vilas, M. M. Corvi, G. J. Plummer, A. M. Seime, G. R. Lambkin, and L. G. Berthiaume Posttranslational myristoylation of caspase-activated p21-activated protein kinase 2 (PAK2) potentiates late apoptotic events PNAS, April 25, 2006; 103(17): 6542 - 6547. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |